RxDoctor Payments Data

Christopher Walker

Family · Parker, CONPI 1023217866

Payments from drug & device makers

$1,514in general payments, 2019–2025

Across 87 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$316
  • Lilly USA, LLC$276
  • AstraZeneca$203
  • Pfizer$182
  • Biohaven Pharmaceutical Holding Company Ltd.$141
  • Amgen$93
  • plus $302 from 9 others

What the payments were for

  • Food & beverage$1,514100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,514 in reported general payments places this provider in the 80th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$20,987
Medicare patients
87
Services billed
378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$49,770
MounjaroTirzepatide22$38,713
FarxigaDapagliflozin Propanediol17$25,406
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$15,700
SymbicortBudesonide/Formoterol Fumarate15$6,005
Albuterol Sulfate HfaAlbuterol Sulfate32$1,551
Atorvastatin Calcium96$779
Levothyroxine Sodium83$678
Gabapentin40$607
Propranolol Hcl15$577
Pregabalin30$562
Omeprazole34$483
Metformin Hcl79$476
Losartan Potassium63$385
Pramipexole DihydrochloridePramipexole Di-Hcl26$368

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$50$49,77032 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$203$47,11148 claims
Lilly USA, LLCMounjaro$276$38,71322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,182 family providers in Colorado.

Other family in Parker

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →